2018-2022 Annual Summary
The following tables provide a summary of Newborn Screening Program data from January 1, 2018 to December 31, 2022. This includes an overview of the number of initial and follow up specimens submitted to the Newborn Screening laboratory, detailed specimen quality metrics, and the number of infants detected through newborn screening during that timeframe.
Detailed annual reports for 2018 to present are in progress. Quarterly reports, which include submitter-specific compliance and quality data, will be available soon through Washington's Newborn Screening Secure Remote Viewer (SRV). If you are not currently registered for SRV, please refer to our SRV webpage for guidance.
If you have questions regarding Newborn Screening statistics and reports, please contact us at 206-418-5410 or email at NBS.Prog@doh.wa.gov.
Overview | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Total Specimens | 168056 | 166126 | 159182 | 160962 | 161911 |
Initial Specimens | 86164 | 85148 | 82928 | 83712 | 83923 |
Subsequent Specimens | 81892 | 80978 | 76254 | 77250 | 77988 |
Unsatisfactory Specimensa | 4144 | 3868 | 4792 | 5524 | 8081 |
Delayed Specimensb | 27023 | 27815 | 29190 | 28526 | 31488 |
a. See Unsatisfactory Specimen Key (PDF) for descriptions and causes of unsatisfactory specimens.
b. Each infant's first newborn screening specimen is required to be received by the State Public Health Laboratories within 72 hours of collection.
Unsatisfactory Specimens | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Incompletely Saturated | 2246 | 2127 | 2107 | 2127 | 3364 |
Layered or Supersaturated | 965 | 1039 | 2063 | 2544 | 3912 |
Contaminated | 119 | 113 | 127 | 190 | 206 |
Abraded | 295 | 278 | 160 | 186 | 159 |
Specimen Too Old | 129 | 140 | 156 | 287 | 306 |
Partial Unsuitable | 48 | 64 | 62 | 84 | 36 |
Other Unsuitable | 342 | 107 | 117 | 106 | 98 |
Infants Diagnosed | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Amino Acid disorders | 12 | 7 | 9 | 3 | 5 |
Biotinidase Deficiency | 3 | 0 | 2 | 1 | 1 |
Congenital Adrenal Hyperplasia | 8 | 7 | 6 | 6 | 6 |
Congenital Hypothyroidism | 76 | 106 | 108 | 132 | 141 |
Cystic Fibrosis | 17 | 11 | 14 | 12 | 14 |
Fatty Acid Oxidation disorders | 15 | 7 | 7 | 6 | 6 |
Galactosemia | 1 | 1 | 3 | 2 | 1 |
Organic Acid disorders | 1 | 0 | 0 | 4 | 1 |
Severe Combined Immunodeficiency | 16 | 12 | 15 | 5 | 6 |
Sickle Cell Disease and Other Clinically Significant Hemoglobinopathies | 17 | 26 | 14 | 17 | 23 |
X-linked adrenoleukodystrophy | 7 | 9 | 13 | 11 | 6 |
Lysosomal storage disorders | - | - | 4 | 4 | 0 |
Spinal muscular atrophy | - | - | 1 | 5 | 5 |
Non-panel disorders | 6 | 4 | 2 | 4 | 2 |
All Infants Detected through Newborn Screening | 179 | 190 | 198 | 212 | 217 |
Past Annual Reports
These annual reports are presented in accordance with Revised Code of Washington (RCW) 70.83.080 and Washington Administrative Code (WAC) 246-650-040, which requires the Department of Health to produce an annual newborn screening report for the State Board of Health and the general public. The annual reports include metrics on specimen collection and transit performance, specimen quality indicators and performance, parent notification, newborn screening disorders detected, and newborn screening follow-up activities.
- 2017 Newborn Screening Program Annual Report (PDF)
- Newborn Screening Program Annual Report - 2016 (PDF)
- Newborn Screening Program Annual Report - 2015 (PDF)
- Newborn Screening Program Annual Report - 2014 (PDF)
Screening and Disorder Summary Statistics
Please visit our Screening and Disorder Summaries webpage for information on the number of infants screened, number of specimens tested, and number of infants diagnosed with newborn screening disorders in Washington State. These statistics are updated quarterly.
Annual Board of Health Report
The Board of Health report is compiled in accordance with Washington Administrative Code (WAC) 246-650-040 which requires an annual report to the State Board of Health detailing newborn screening follow-up procedures and annual data on infants screened, infants detected, and the cost of screening. Starting in 2015, the Annual Board of Health Report has been combined with the Newborn Screening Program Annual Report.